Biotechnology
The Biotechnology industry has a total of 606 stocks, with a combined market cap of $1.13 trillion and total revenue of $105.47 billion.
Market Cap
1.13T
Revenue
105.47B
Profits
-42.15B
PE Ratio
n/a
Profit Margin
-39.96%
Dividend Yield
0.04%
606 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.45B | -0.02% | 388,069 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.54B | 0.16% | 321,116 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 52.92B | -0.02% | 401,419 | 3.21B |
| 4 | ARGX | argenx SE | 51.79B | -0.59% | 102,716 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.94B | 0.26% | 1,035,787 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 34.57B | 0.21% | 97,273 | 4.97B |
| 7 | BNTX | BioNTech SE | 22.73B | -0.54% | 484,940 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.64B | -0.08% | 1,344,266 | 2.35B |
| 9 | GMAB | Genmab A/S | 20.62B | -0.89% | 577,469 | 3.85B |
| 10 | INCY | Incyte Corporation | 19.65B | -0.33% | 605,927 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.61B | -0.54% | 1,081,971 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 15.46B | -1.20% | 4,265,047 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.61B | -0.95% | 1,069,663 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.99B | -1.31% | 1,196,958 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.60B | -0.65% | 97,631 | 740.64M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.95B | -0.89% | 719,788 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.77B | -1.80% | 267,040 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 12.45B | -0.58% | 1,537,684 | 2.29B |
| 19 | MRNA | Moderna, Inc. | 12.19B | -4.73% | 6,322,758 | 2.23B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.52B | -0.35% | 1,181,150 | 3.09B |
| 21 | ABVX | ABIVAX Société Anonyme | 11.18B | -2.06% | 664,902 | 6.23M |
| 22 | RNA | Avidity Biosciences, Inc. | 10.87B | -0.07% | 684,492 | 20.87M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.36B | -0.19% | 254,671 | 4.16B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.53B | 0.07% | 802,372 | 829.45M |
| 25 | TECH | Bio-Techne Corporation | 9.23B | 0.05% | 559,141 | 1.22B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.69B | -1.12% | 342,899 | 741.17M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.10B | 0.67% | 604,902 | 1.24B |
| 28 | NUVL | Nuvalent, Inc. | 8.08B | -1.57% | 204,560 | - |
| 29 | CAI | Caris Life Sciences, Inc. | 7.97B | -0.02% | 683,766 | 649.06M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.72B | -1.67% | 1,385,335 | 87.21M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 7.67B | -1.03% | 460,371 | 561.26M |
| 32 | MRUS | Merus N.V. | 7.35B | 0.01% | 361,126 | 56.61M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.34B | -2.02% | 459,857 | 174.33M |
| 34 | KRYS | Krystal Biotech, Inc. | 7.31B | 0.35% | 149,737 | 373.16M |
| 35 | CDTX | Cidara Therapeutics, Inc. | 6.96B | -0.03% | 424,397 | 302.00K |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 6.73B | -2.11% | 247,195 | 7.46M |
| 37 | KYMR | Kymera Therapeutics, Inc. | 6.51B | -2.18% | 418,607 | 43.74M |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.31B | 0.19% | 491,624 | 1.78B |
| 39 | PCVX | Vaxcyte, Inc. | 6.15B | -1.43% | 527,073 | - |
| 40 | COGT | Cogent Biosciences, Inc. | 5.91B | -2.14% | 1,099,004 | - |
| 41 | BLTE | Belite Bio, Inc | 5.81B | -0.05% | 71,994 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.55B | -0.07% | 390,098 | 209.22M |
| 43 | IMVT | Immunovant, Inc. | 5.30B | -2.68% | 1,077,833 | - |
| 44 | CRSP | CRISPR Therapeutics AG | 5.25B | -2.87% | 1,410,168 | 38.34M |
| 45 | APGE | Apogee Therapeutics, Inc. | 5.22B | -0.99% | 554,715 | - |
| 46 | CELC | Celcuity Inc. | 4.73B | -0.35% | 349,090 | - |
| 47 | GPCR | Structure Therapeutics Inc. | 4.72B | -1.94% | 467,031 | - |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.67B | -0.90% | 620,646 | 1.05B |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.66B | -0.41% | 510,782 | - |
| 50 | ADMA | ADMA Biologics, Inc. | 4.59B | -1.33% | 1,115,951 | 488.56M |
| 51 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.55B | -1.54% | 408,194 | 1.54M |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.52B | -2.03% | 974,078 | - |
| 53 | TGTX | TG Therapeutics, Inc. | 4.50B | -0.97% | 767,927 | 531.90M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 4.40B | - | 5,180,101 | 598.70M |
| 55 | VKTX | Viking Therapeutics, Inc. | 4.20B | -0.46% | 1,633,155 | - |
| 56 | LEGN | Legend Biotech Corporation | 4.16B | -1.96% | 887,494 | 909.05M |
| 57 | MIRM | Mirum Pharmaceuticals, Inc. | 4.07B | -1.85% | 318,532 | 471.79M |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 4.00B | -1.07% | 323,113 | 35.24M |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 3.85B | -0.66% | 88,231 | 251.23M |
| 60 | VERA | Vera Therapeutics, Inc. | 3.80B | -3.75% | 697,419 | - |
| 61 | ACLX | Arcellx, Inc. | 3.80B | -0.44% | 355,929 | 35.90M |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.70B | -1.36% | 464,794 | 15.00M |
| 63 | ARQT | Arcutis Biotherapeutics, Inc. | 3.55B | -1.63% | 1,312,836 | 317.93M |
| 64 | TVTX | Travere Therapeutics, Inc. | 3.55B | -1.59% | 1,807,094 | 435.83M |
| 65 | TARS | Tarsus Pharmaceuticals, Inc. | 3.47B | -0.88% | 240,993 | 366.10M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.47B | -0.38% | 310,088 | 7.50M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.30B | -1.52% | 964,713 | - |
| 68 | RARE | Ultragenyx Pharmaceutical Inc. | 3.29B | -1.13% | 621,756 | 630.60M |
| 69 | WVE | Wave Life Sciences Ltd. | 3.25B | -2.63% | 1,613,394 | 109.23M |
| 70 | NUVB | Nuvation Bio Inc. | 3.22B | -1.26% | 3,602,032 | 26.75M |
| 71 | CGON | CG Oncology, Inc. | 3.21B | -0.75% | 559,686 | 2.17M |
| 72 | APLS | Apellis Pharmaceuticals, Inc. | 3.16B | -0.76% | 786,630 | 1.02B |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 3.09B | -1.40% | 449,452 | 214.83M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 3.04B | -1.24% | 453,548 | 70.79M |
| 75 | IRON | Disc Medicine, Inc. | 3.03B | -0.12% | 217,565 | - |
| 76 | LQDA | Liquidia Corporation | 2.99B | -3.86% | 667,110 | 69.22M |
| 77 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.99B | -0.41% | 702,556 | 578.20M |
| 78 | MLYS | Mineralys Therapeutics, Inc. | 2.94B | -0.77% | 800,238 | - |
| 79 | RCUS | Arcus Biosciences, Inc. | 2.86B | -0.13% | 694,857 | 240.00M |
| 80 | EWTX | Edgewise Therapeutics, Inc. | 2.79B | -3.44% | 2,412,825 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.76B | -0.57% | 1,006,299 | 55.70M |
| 82 | TLX | Telix Pharmaceuticals Limited | 2.70B | -0.86% | 115,730 | 664.23M |
| 83 | OCUL | Ocular Therapeutix, Inc. | 2.68B | -1.18% | 1,151,530 | 55.78M |
| 84 | DNLI | Denali Therapeutics Inc. | 2.63B | -0.71% | 677,979 | - |
| 85 | SLNO | Soleno Therapeutics, Inc. | 2.56B | -3.03% | 563,187 | 98.68M |
| 86 | SYRE | Spyre Therapeutics, Inc. | 2.56B | -0.33% | 307,908 | - |
| 87 | ADPT | Adaptive Biotechnologies Corporation | 2.55B | 0.12% | 903,383 | 252.75M |
| 88 | AAPG | Ascentage Pharma Group International | 2.54B | -0.72% | 3,887 | 54.52M |
| 89 | MESO | Mesoblast Limited | 2.50B | 0.52% | 115,404 | 17.20M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.32B | -0.90% | 1,388,030 | 2.41B |
| 91 | ZBIO | Zenas BioPharma, Inc. | 2.28B | -1.58% | 134,333 | 15.00M |
| 92 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | -3.41% | 15,946,347 | 43.69M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.20B | -0.94% | 329,973 | 825.94M |
| 94 | GLPG | Galapagos NV | 2.17B | 0.12% | 61,172 | 336.64M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.18% | 489,004 | 265.81M |
| 96 | IBRX | ImmunityBio, Inc. | 2.11B | - | 7,221,023 | 82.56M |
| 97 | OLMA | Olema Pharmaceuticals, Inc. | 2.06B | -4.44% | 785,662 | - |
| 98 | ZLAB | Zai Lab Limited | 2.04B | -1.35% | 495,023 | 441.63M |
| 99 | MAZE | Maze Therapeutics, Inc. | 2.03B | 0.05% | 212,857 | 2.50M |
| 100 | ZYME | Zymeworks Inc. | 2.01B | 0.04% | 237,827 | 134.48M |
| 101 | IMNM | Immunome, Inc. | 1.99B | -2.78% | 1,037,684 | 9.68M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.96B | -0.31% | 794,351 | 83.69M |
| 103 | SION | Sionna Therapeutics, Inc. | 1.95B | -0.75% | 165,962 | - |
| 104 | VCEL | Vericel Corporation | 1.90B | 0.27% | 537,208 | 258.72M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -1.39% | 887,064 | 111.30M |
| 106 | IMCR | Immunocore Holdings plc | 1.83B | -1.20% | 107,586 | 379.59M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.82B | -0.78% | 404,360 | 205.63M |
| 108 | DNTH | Dianthus Therapeutics, Inc. | 1.79B | -3.06% | 316,903 | 3.08M |
| 109 | MNKD | MannKind Corporation | 1.78B | -2.36% | 2,403,267 | 313.79M |
| 110 | CLDX | Celldex Therapeutics, Inc. | 1.75B | -1.68% | 353,894 | 2.60M |
| 111 | PHVS | Pharvaris N.V. | 1.67B | -0.66% | 60,980 | - |
| 112 | TRVI | Trevi Therapeutics, Inc. | 1.65B | -0.93% | 1,193,599 | - |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | -3.94% | 1,705,616 | 44.79M |
| 114 | FTRE | Fortrea Holdings Inc. | 1.61B | -1.69% | 831,530 | 2.76B |
| 115 | TSHA | Taysha Gene Therapies, Inc. | 1.60B | -1.35% | 1,144,066 | 6.31M |
| 116 | UPB | Upstream Bio, Inc. | 1.59B | -2.61% | 228,013 | 2.80M |
| 117 | KOD | Kodiak Sciences Inc. | 1.58B | -3.83% | 965,014 | - |
| 118 | SVRA | Savara Inc. | 1.56B | 0.78% | 948,030 | - |
| 119 | QURE | uniQure N.V. | 1.55B | -1.51% | 861,113 | 15.75M |
| 120 | CAPR | Capricor Therapeutics, Inc. | 1.54B | 0.03% | 908,378 | 11.13M |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.53B | -1.31% | 378,707 | - |
| 122 | EYPT | EyePoint, Inc. | 1.51B | 0.16% | 807,759 | 42.34M |
| 123 | RLAY | Relay Therapeutics, Inc. | 1.48B | -1.04% | 1,107,436 | 8.36M |
| 124 | INVA | Innoviva, Inc. | 1.48B | 0.15% | 369,681 | 388.52M |
| 125 | BHVN | Biohaven Ltd. | 1.48B | 3.15% | 8,260,582 | - |
| 126 | ATAI | Atai Beckley N.V. | 1.48B | -2.86% | 3,027,015 | 3.02M |
| 127 | PGEN | Precigen, Inc. | 1.47B | -0.72% | 2,812,597 | 6.31M |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.44B | -2.36% | 221,850 | - |
| 129 | ARDX | Ardelyx, Inc. | 1.39B | -4.17% | 2,046,855 | 398.23M |
| 130 | MBX | MBX Biosciences, Inc. | 1.39B | -3.77% | 429,569 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.39B | 0.18% | 197,905 | 169.47M |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.39B | -0.31% | 238,711 | - |
| 133 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.35B | -1.28% | 819,207 | -665.00K |
| 134 | MNMD | Mind Medicine (MindMed) Inc. | 1.29B | -2.76% | 1,488,339 | - |
| 135 | SEPN | Septerna, Inc. | 1.28B | -2.88% | 114,992 | 22.05M |
| 136 | IMTX | Immatics N.V. | 1.24B | -1.45% | 159,670 | 99.45M |
| 137 | PVLA | Palvella Therapeutics, Inc. | 1.22B | -2.32% | 124,803 | - |
| 138 | PHAT | Phathom Pharmaceuticals, Inc. | 1.22B | -0.57% | 362,535 | 147.19M |
| 139 | XERS | Xeris Biopharma Holdings, Inc. | 1.22B | 2.22% | 1,101,261 | 266.14M |
| 140 | OCS | Oculis Holding AG | 1.19B | -0.92% | 59,056 | 992.00K |
| 141 | SANA | Sana Biotechnology, Inc. | 1.17B | -2.65% | 1,749,261 | - |
| 142 | TNGX | Tango Therapeutics, Inc. | 1.17B | -0.34% | 1,588,567 | 66.50M |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.17B | -0.19% | 95,899 | 1.40M |
| 144 | PHAR | Pharming Group N.V. | 1.16B | -1.60% | 20,818 | 362.27M |
| 145 | ALMS | Alumis Inc. | 1.15B | -3.77% | 702,439 | 22.12M |
| 146 | IOVA | Iovance Biotherapeutics, Inc. | 1.13B | -0.70% | 8,109,498 | 250.43M |
| 147 | GLUE | Monte Rosa Therapeutics, Inc. | 1.13B | -1.98% | 616,025 | 181.54M |
| 148 | SPRY | ARS Pharmaceuticals, Inc. | 1.12B | -0.87% | 1,032,409 | 142.77M |
| 149 | NBTX | Nanobiotix S.A. | 1.12B | 1.72% | 15,158 | 11.93M |
| 150 | OMER | Omeros Corporation | 1.11B | 2.28% | 7,163,986 | - |
| 151 | NVAX | Novavax, Inc. | 1.11B | -1.59% | 1,993,555 | 1.06B |
| 152 | NTLA | Intellia Therapeutics, Inc. | 1.09B | -1.56% | 1,839,737 | 57.53M |
| 153 | XNCR | Xencor, Inc. | 1.09B | -1.49% | 421,713 | 150.13M |
| 154 | URGN | UroGen Pharma Ltd. | 1.08B | -3.07% | 250,878 | 96.52M |
| 155 | ABCL | AbCellera Biologics Inc. | 1.07B | -3.76% | 2,617,065 | 35.33M |
| 156 | MDXG | MiMedx Group, Inc. | 1.02B | -2.54% | 1,678,379 | 393.44M |
| 157 | ERAS | Erasca, Inc. | 987.32M | 1.46% | 998,050 | - |
| 158 | CRMD | CorMedix Inc. | 987.23M | 2.79% | 1,943,795 | 214.30M |
| 159 | MLTX | MoonLake Immunotherapeutics | 987.10M | -0.29% | 917,771 | - |
| 160 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 986.26M | 1.07% | 87,888 | - |
| 161 | RAPT | RAPT Therapeutics, Inc. | 981.52M | -1.17% | 115,588 | - |
| 162 | DAWN | Day One Biopharmaceuticals, Inc. | 970.28M | -1.56% | 848,833 | 133.67M |
| 163 | CVAC | CureVac N.V. | 968.28M | -0.23% | 317,255 | 83.00M |
| 164 | ELVN | Enliven Therapeutics, Inc. | 967.36M | -2.57% | 474,038 | - |
| 165 | TBPH | Theravance Biopharma, Inc. | 954.67M | 0.59% | 204,813 | 80.33M |
| 166 | KURA | Kura Oncology, Inc. | 925.00M | -3.89% | 1,168,989 | 104.03M |
| 167 | BCAX | Bicara Therapeutics Inc. | 920.34M | -2.72% | 275,688 | - |
| 168 | CMPX | Compass Therapeutics, Inc. | 919.55M | 0.58% | 946,089 | 850.00K |
| 169 | ABUS | Arbutus Biopharma Corporation | 919.31M | -0.21% | 600,277 | 14.61M |
| 170 | AVBP | ArriVent BioPharma, Inc. | 906.95M | -1.44% | 210,896 | - |
| 171 | NKTR | Nektar Therapeutics | 905.00M | 1.25% | 406,258 | 62.60M |
| 172 | GERN | Geron Corporation | 874.55M | -2.14% | 3,511,236 | 183.40M |
| 173 | YDES | YD Bio Limited | 860.71M | -1.92% | 66,720 | 510.36K |
| 174 | JANX | Janux Therapeutics, Inc. | 857.11M | -0.42% | 1,884,323 | 10.00M |
| 175 | IVA | Inventiva S.A. | 845.83M | 0.90% | 391,679 | 19.93M |
| 176 | MRVI | Maravai LifeSciences Holdings, Inc. | 836.16M | -1.21% | 1,759,172 | 192.44M |
| 177 | VIR | Vir Biotechnology, Inc. | 834.75M | -1.80% | 1,195,229 | 16.86M |
| 178 | ORIC | ORIC Pharmaceuticals, Inc. | 803.46M | -2.14% | 904,042 | - |
| 179 | RIGL | Rigel Pharmaceuticals, Inc. | 798.84M | -1.41% | 629,674 | 282.08M |
| 180 | MPLT | MapLight Therapeutics, Inc. | 785.98M | -0.61% | 96,346 | - |
| 181 | GHRS | GH Research PLC | 781.57M | -1.49% | 146,669 | - |
| 182 | REPL | Replimune Group, Inc. | 781.30M | -1.29% | 749,139 | - |
| 183 | ARVN | Arvinas, Inc. | 780.97M | -0.08% | 361,040 | 312.30M |
| 184 | KALV | KalVista Pharmaceuticals, Inc. | 766.79M | -3.93% | 723,740 | 1.43M |
| 185 | FULC | Fulcrum Therapeutics, Inc. | 763.94M | -3.58% | 459,442 | 80.00M |
| 186 | ANNX | Annexon, Inc. | 761.68M | -1.35% | 1,669,246 | - |
| 187 | PROK | ProKidney Corp. | 761.11M | -1.56% | 690,392 | 744.00K |
| 188 | JBIO | Jade Biosciences, Inc. | 756.77M | -0.48% | 226,064 | - |
| 189 | LXEO | Lexeo Therapeutics, Inc. | 748.12M | -2.94% | 496,987 | - |
| 190 | GOSS | Gossamer Bio, Inc. | 747.60M | -6.10% | 4,366,354 | 44.05M |
| 191 | LYEL | Lyell Immunopharma, Inc. | 744.55M | -9.09% | 127,326 | 41.00K |
| 192 | CTMX | CytomX Therapeutics, Inc. | 743.82M | -0.23% | 1,392,530 | 113.63M |
| 193 | ATXS | Astria Therapeutics, Inc. | 739.25M | -0.23% | 310,362 | 706.00K |
| 194 | VALN | Valneva SE | 729.63M | -0.88% | 13,236 | 211.09M |
| 195 | RGNX | REGENXBIO Inc. | 716.82M | -2.07% | 276,508 | 161.32M |
| 196 | DBVT | DBV Technologies S.A. | 677.04M | 0.74% | 163,063 | 5.50M |
| 197 | DRUG | Bright Minds Biosciences Inc. | 671.82M | -3.00% | 188,000 | - |
| 198 | VTYX | Ventyx Biosciences, Inc. | 660.78M | 0.87% | 488,634 | - |
| 199 | GYRE | Gyre Therapeutics, Inc. | 659.86M | 0.97% | 85,620 | 107.27M |
| 200 | MGTX | MeiraGTx Holdings plc | 641.51M | -3.63% | 267,450 | 27.42M |
| 201 | KROS | Keros Therapeutics, Inc. | 640.70M | -1.54% | 310,800 | 246.72M |
| 202 | ENGN | enGene Holdings Inc. | 636.35M | 0.53% | 142,788 | - |
| 203 | IVVD | Invivyd, Inc. | 627.10M | -4.27% | 2,368,476 | 50.04M |
| 204 | VSTM | Verastem, Inc. | 622.09M | 2.41% | 891,188 | 13.38M |
| 205 | PRME | Prime Medicine, Inc. | 619.63M | -1.96% | 2,587,672 | 5.98M |
| 206 | CGEM | Cullinan Therapeutics, Inc. | 612.62M | 1.07% | 809,628 | - |
| 207 | NBY | NovaBay Pharmaceuticals, Inc. | 611.15M | 2.11% | 244,160 | 10.30M |
| 208 | CRVS | Corvus Pharmaceuticals, Inc. | 575.05M | 2.94% | 1,067,242 | - |
| 209 | ANRO | Alto Neuroscience, Inc. | 572.55M | -7.29% | 305,729 | - |
| 210 | VOR | Vor Biopharma Inc. | 569.96M | 1.31% | 630,114 | - |
| 211 | DSGN | Design Therapeutics, Inc. | 548.56M | -1.13% | 111,454 | - |
| 212 | LBRX | LB Pharmaceuticals Inc | 544.69M | -2.14% | 150,769 | - |
| 213 | EVMN | Evommune, Inc. | 542.53M | -2.16% | 135,710 | 13.00M |
| 214 | ABSI | Absci Corporation | 536.83M | 0.28% | 1,831,787 | 2.82M |
| 215 | NAGE | Niagen Bioscience, Inc. | 531.79M | 0.45% | 644,171 | 124.71M |
| 216 | ASMB | Assembly Biosciences, Inc. | 531.77M | -1.12% | 87,594 | 37.19M |
| 217 | LENZ | LENZ Therapeutics, Inc. | 527.86M | -1.58% | 536,478 | 17.50M |
| 218 | TENX | Tenax Therapeutics, Inc. | 514.03M | 0.96% | 117,874 | - |
| 219 | PRTA | Prothena Corporation plc | 513.54M | -1.55% | 422,345 | 11.79M |
| 220 | NBP | NovaBridge Biosciences | 500.36M | -6.26% | 479,959 | - |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 499.36M | 2.66% | 723,570 | 84.39M |
| 222 | FBRX | Forte Biosciences, Inc. | 496.96M | 1.57% | 144,285 | - |
| 223 | ENTA | Enanta Pharmaceuticals, Inc. | 486.33M | 1.51% | 251,280 | 65.32M |
| 224 | DNA | Ginkgo Bioworks Holdings, Inc. | 477.42M | -5.72% | 797,313 | 180.61M |
| 225 | BCYC | Bicycle Therapeutics plc | 473.09M | -2.43% | 157,520 | 28.34M |
| 226 | VTVT | vTv Therapeutics Inc. | 470.42M | 2.43% | 7,722 | 17.00K |
| 227 | MNPR | Monopar Therapeutics Inc. | 459.56M | -3.00% | 605,936 | - |
| 228 | FDMT | 4D Molecular Therapeutics, Inc. | 455.37M | -1.60% | 762,916 | 120.00K |
| 229 | SLDB | Solid Biosciences Inc. | 455.00M | -1.02% | 481,443 | - |
| 230 | LXRX | Lexicon Pharmaceuticals, Inc. | 446.98M | - | 896,091 | 70.86M |
| 231 | AUTL | Autolus Therapeutics plc | 444.46M | -0.60% | 753,365 | 51.13M |
| 232 | BNTC | Benitec Biopharma Inc. | 443.60M | 0.38% | 73,489 | - |
| 233 | OCGN | Ocugen, Inc. | 440.37M | -2.08% | 2,296,258 | 5.37M |
| 234 | DRTS | Alpha Tau Medical Ltd. | 434.85M | 0.99% | 59,625 | - |
| 235 | ADCT | ADC Therapeutics SA | 434.81M | -0.57% | 549,148 | 75.21M |
| 236 | IMRX | Immuneering Corporation | 434.56M | -1.17% | 1,300,685 | - |
| 237 | DMAC | DiaMedica Therapeutics Inc. | 428.60M | -2.83% | 130,649 | - |
| 238 | CYBN | Cybin Inc. | 416.20M | 2.21% | 1,022,507 | - |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 416.04M | 1.88% | 1,361,538 | 212.07M |
| 240 | PRTC | PureTech Health plc | 411.79M | -0.21% | 458 | 6.39M |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 411.68M | 4.56% | 1,072,499 | - |
| 242 | IMMP | Immutep Limited | 410.36M | 1.62% | 684,284 | 3.31M |
| 243 | SLS | SELLAS Life Sciences Group, Inc. | 408.81M | 1.06% | 4,373,349 | - |
| 244 | ALT | Altimmune, Inc. | 402.76M | -3.02% | 2,923,079 | 20.00K |
| 245 | LCTX | Lineage Cell Therapeutics, Inc. | 399.84M | -1.79% | 721,670 | 10.82M |
| 246 | PEPG | PepGen Inc. | 399.43M | 0.52% | 255,529 | - |
| 247 | XFOR | X4 Pharmaceuticals, Inc. | 393.47M | 1.81% | 536,937 | 33.98M |
| 248 | TECX | Tectonic Therapeutic, Inc. | 390.80M | -4.22% | 182,954 | - |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 376.61M | -0.85% | 933,500 | - |
| 250 | TRDA | Entrada Therapeutics, Inc. | 373.32M | -1.61% | 173,141 | 61.52M |
| 251 | AURA | Aura Biosciences, Inc. | 372.76M | -0.17% | 98,688 | - |
| 252 | EPRX | Eupraxia Pharmaceuticals Inc. | 371.04M | 2.86% | 93,113 | - |
| 253 | MREO | Mereo BioPharma Group plc | 367.59M | 0.43% | 871,093 | 500.00K |
| 254 | CTNM | Contineum Therapeutics, Inc. | 362.15M | -2.13% | 95,611 | - |
| 255 | CLLS | Cellectis S.A. | 352.17M | -1.86% | 39,146 | 82.55M |
| 256 | LRMR | Larimar Therapeutics, Inc. | 336.37M | -1.01% | 738,951 | - |
| 257 | AVTX | Avalo Therapeutics, Inc. | 333.12M | -2.86% | 138,141 | 192.00K |
| 258 | RLMD | Relmada Therapeutics, Inc. | 330.73M | -1.96% | 236,674 | - |
| 259 | CADL | Candel Therapeutics, Inc. | 329.94M | -1.15% | 302,216 | - |
| 260 | ACRS | Aclaris Therapeutics, Inc. | 328.29M | -0.33% | 497,686 | 15.74M |
| 261 | AVXL | Anavex Life Sciences Corp. | 325.23M | -2.15% | 1,614,383 | - |
| 262 | XOMA | XOMA Royalty Corporation | 322.70M | 0.27% | 142,805 | 47.11M |
| 263 | PALI | Palisade Bio, Inc. | 320.36M | -2.27% | 1,313,274 | - |
| 264 | ALDX | Aldeyra Therapeutics, Inc. | 319.46M | 0.57% | 508,664 | - |
| 265 | GUTS | Fractyl Health, Inc. | 311.09M | 0.89% | 1,107,732 | 3.00K |
| 266 | PBYI | Puma Biotechnology, Inc. | 310.41M | 3.36% | 458,036 | 212.00M |
| 267 | ALLO | Allogene Therapeutics, Inc. | 310.13M | -1.43% | 2,195,695 | 22.00K |
| 268 | NGNE | Neurogene Inc. | 309.95M | -0.30% | 59,598 | 925.00K |
| 269 | ACIU | AC Immune SA | 309.69M | - | 243,061 | 5.48M |
| 270 | FHTX | Foghorn Therapeutics Inc. | 305.38M | - | 70,262 | 24.52M |
| 271 | NMRA | Neumora Therapeutics, Inc. | 302.49M | -1.66% | 533,331 | - |
| 272 | ZURA | Zura Bio Limited | 302.36M | 3.33% | 1,021,666 | - |
| 273 | TARA | Protara Therapeutics, Inc. | 297.41M | 1.09% | 384,141 | - |
| 274 | AARD | Aardvark Therapeutics, Inc. | 297.21M | -4.28% | 75,893 | - |
| 275 | IMMX | Immix Biopharma, Inc. | 297.20M | -1.74% | 511,865 | - |
| 276 | ABEO | Abeona Therapeutics Inc. | 295.34M | 0.74% | 519,787 | 400.00K |
| 277 | SLN | Silence Therapeutics plc | 292.85M | 0.98% | 156,514 | 25.83M |
| 278 | GLSI | Greenwich LifeSciences, Inc. | 286.58M | 20.19% | 1,266,022 | - |
| 279 | AVIR | Atea Pharmaceuticals, Inc. | 285.16M | 0.83% | 375,277 | - |
| 280 | CAMP | Camp4 Therapeutics Corporation | 279.41M | 0.68% | 93,536 | 3.80M |
| 281 | OABI | OmniAb, Inc. | 277.83M | -1.53% | 200,371 | 21.09M |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 276.30M | 5.48% | 156,777 | 38.79M |
| 283 | IKT | Inhibikase Therapeutics, Inc. | 273.57M | 21.21% | 2,079,890 | 1.00 |
| 284 | GALT | Galectin Therapeutics Inc. | 261.11M | 0.50% | 413,763 | - |
| 285 | NAUT | Nautilus Biotechnology, Inc. | 250.08M | -1.00% | 171,448 | - |
| 286 | MENS | Jyong Biotech Ltd. | 247.62M | -9.55% | 860,226 | - |
| 287 | RZLT | Rezolute, Inc. | 247.58M | -2.55% | 5,719,478 | - |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 243.93M | -0.23% | 75,647 | 2.82M |
| 289 | CBIO | Crescent Biopharma, Inc. | 241.44M | -0.16% | 43,144 | - |
| 290 | MDWD | MediWound Ltd. | 240.91M | -0.48% | 30,891 | 20.93M |
| 291 | ARMP | Armata Pharmaceuticals, Inc. | 239.56M | 2.65% | 3,689 | 5.05M |
| 292 | ACHV | Achieve Life Sciences, Inc. | 238.75M | 0.56% | 225,608 | - |
| 293 | CLYM | Climb Bio, Inc. | 235.38M | 1.65% | 774,642 | - |
| 294 | HRTX | Heron Therapeutics, Inc. | 234.70M | - | 899,031 | 155.10M |
| 295 | OVID | Ovid Therapeutics Inc. | 231.73M | - | 855,835 | 6.61M |
| 296 | PRQR | ProQR Therapeutics N.V. | 228.60M | - | 588,901 | 18.86M |
| 297 | VYGR | Voyager Therapeutics, Inc. | 226.85M | 0.25% | 218,761 | 31.32M |
| 298 | CRDF | Cardiff Oncology, Inc. | 213.53M | -0.31% | 1,170,630 | 501.00K |
| 299 | STTK | Shattuck Labs, Inc. | 211.99M | 2.13% | 223,087 | 1.00M |
| 300 | EDIT | Editas Medicine, Inc. | 211.83M | -1.81% | 1,259,154 | 46.38M |
| 301 | MIST | Milestone Pharmaceuticals Inc. | 211.29M | 0.48% | 3,850,096 | - |
| 302 | CABA | Cabaletta Bio, Inc. | 210.82M | - | 743,656 | - |
| 303 | CCCC | C4 Therapeutics, Inc. | 205.46M | 1.92% | 1,135,220 | 30.11M |
| 304 | PRLD | Prelude Therapeutics Incorporated | 201.87M | 9.87% | 265,418 | 10.50M |
| 305 | HUMA | Humacyte, Inc. | 200.38M | -0.93% | 3,667,331 | 1.57M |
| 306 | NVCT | Nuvectis Pharma, Inc. | 198.52M | 0.52% | 22,642 | - |
| 307 | QNCX | Quince Therapeutics, Inc. | 198.23M | -2.73% | 388,155 | - |
| 308 | SGMT | Sagimet Biosciences Inc. | 193.83M | -1.65% | 239,890 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.49M | -3.16% | 367,566 | 10.30M |
| 310 | SRZN | Surrozen, Inc. | 190.29M | -3.06% | 29,409 | 3.60M |
| 311 | SABS | SAB Biotherapeutics, Inc. | 179.95M | -1.56% | 62,851 | 114.70K |
| 312 | TLSA | Tiziana Life Sciences Ltd | 175.86M | -3.27% | 101,503 | - |
| 313 | ARCT | Arcturus Therapeutics Holdings Inc. | 175.02M | -5.23% | 441,878 | 97.60M |
| 314 | RNAC | Cartesian Therapeutics, Inc. | 173.70M | -1.18% | 157,033 | 1.09M |
| 315 | KLRS | Kalaris Therapeutics, Inc. | 173.09M | -3.39% | 91,644 | - |
| 316 | RANI | Rani Therapeutics Holdings, Inc. | 170.13M | -5.41% | 3,046,492 | 1.20M |
| 317 | IPHA | Innate Pharma S.A. | 168.03M | 2.94% | 23,107 | 14.84M |
| 318 | NTHI | NeOnc Technologies Holdings, Inc. | 166.89M | 2.63% | 25,996 | 59.99K |
| 319 | GNLX | Genelux Corporation | 164.39M | -0.68% | 45,004 | 8.00K |
| 320 | MOLN | Molecular Partners AG | 162.28M | -2.53% | 3,736 | 856.30K |
| 321 | CHRS | Coherus Oncology, Inc. | 160.76M | -0.75% | 292,453 | 277.73M |
| 322 | CRBU | Caribou Biosciences, Inc. | 158.90M | -1.16% | 779,454 | 9.30M |
| 323 | ALEC | Alector, Inc. | 158.27M | - | 639,978 | 69.05M |
| 324 | INO | Inovio Pharmaceuticals, Inc. | 157.33M | 1.78% | 543,025 | 182.34K |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 154.34M | -1.19% | 138,995 | - |
| 326 | CNTB | Connect Biopharma Holdings Limited | 150.38M | -1.47% | 60,472 | 762.00K |
| 327 | ACTU | Actuate Therapeutics, Inc. | 150.27M | -1.45% | 13,567 | - |
| 328 | BDTX | Black Diamond Therapeutics, Inc. | 147.57M | -3.00% | 836,073 | 70.00M |
| 329 | CDXS | Codexis, Inc. | 147.23M | -2.98% | 338,239 | 52.93M |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 145.56M | 2.26% | 373,394 | 61.84M |
| 331 | MRSN | Mersana Therapeutics, Inc. | 145.34M | -0.09% | 81,810 | 33.18M |
| 332 | CGEN | Compugen Ltd. | 144.04M | - | 143,392 | 6.90M |
| 333 | SGMO | Sangamo Therapeutics, Inc. | 143.01M | -4.49% | 4,253,280 | 32.88M |
| 334 | ELTX | Elicio Therapeutics, Inc. | 141.02M | -1.47% | 54,931 | - |
| 335 | IRD | Opus Genetics, Inc. | 139.31M | -0.98% | 217,597 | 14.63M |
| 336 | ACOG | Alpha Cognition Inc. | 136.21M | 0.24% | 56,959 | 7.43M |
| 337 | MCRB | Seres Therapeutics, Inc. | 132.53M | -4.25% | 34,605 | 351.00K |
| 338 | SPRO | Spero Therapeutics, Inc. | 130.71M | -0.85% | 279,549 | 40.55M |
| 339 | NKTX | Nkarta, Inc. | 130.69M | 1.66% | 314,299 | - |
| 340 | VRCA | Verrica Pharmaceuticals Inc. | 130.48M | -2.04% | 129,134 | 30.83M |
| 341 | UNCY | Unicycive Therapeutics, Inc. | 130.45M | 3.58% | 198,894 | - |
| 342 | CGTX | Cognition Therapeutics, Inc. | 128.00M | -0.68% | 434,364 | - |
| 343 | ABOS | Acumen Pharmaceuticals, Inc. | 127.81M | -2.31% | 92,837 | - |
| 344 | KPTI | Karyopharm Therapeutics Inc. | 126.86M | -0.40% | 106,287 | 142.53M |
| 345 | WHWK | Whitehawk Therapeutics, Inc. | 125.83M | -0.74% | 208,060 | 14.38M |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 125.56M | 1.22% | 2,342,265 | - |
| 347 | ATRA | Atara Biotherapeutics, Inc. | 124.52M | -1.82% | 71,061 | 151.93M |
| 348 | GANX | Gain Therapeutics, Inc. | 121.16M | -2.17% | 576,215 | - |
| 349 | DWTX | Dogwood Therapeutics, Inc. | 120.99M | -7.08% | 33,884 | - |
| 350 | ELDN | Eledon Pharmaceuticals, Inc. | 120.24M | 1.91% | 434,661 | - |
| 351 | ORMP | Oramed Pharmaceuticals Inc. | 117.42M | -6.35% | 103,507 | 2.00M |
| 352 | OTLK | Outlook Therapeutics, Inc. | 116.69M | -0.55% | 4,535,908 | 1.41M |
| 353 | SLGL | Sol-Gel Technologies Ltd. | 116.59M | -3.86% | 28,808 | 18.97M |
| 354 | FBIO | Fortress Biotech, Inc. | 116.08M | 1.91% | 447,681 | 62.30M |
| 355 | FATE | Fate Therapeutics, Inc. | 115.35M | -0.99% | 991,755 | 7.14M |
| 356 | COYA | Coya Therapeutics, Inc. | 114.46M | -1.44% | 89,020 | 3.99M |
| 357 | AGEN | Agenus Inc. | 112.57M | -1.19% | 733,393 | 106.83M |
| 358 | RPTX | Repare Therapeutics Inc. | 110.79M | 0.78% | 828,457 | 11.87M |
| 359 | ANIX | Anixa Biosciences, Inc. | 105.33M | -6.43% | 226,164 | - |
| 360 | SAVA | Cassava Sciences, Inc. | 105.31M | -2.24% | 538,530 | - |
| 361 | CNTX | Context Therapeutics Inc. | 103.82M | -1.74% | 109,314 | - |
| 362 | SEER | Seer, Inc. | 102.65M | - | 206,620 | 16.38M |
| 363 | ARTV | Artiva Biotherapeutics, Inc. | 102.60M | -2.79% | 178,727 | 251.00K |
| 364 | ONCY | Oncolytics Biotech Inc. | 102.44M | -1.86% | 274,600 | - |
| 365 | MGNX | MacroGenics, Inc. | 101.85M | -0.62% | 443,941 | 127.63M |
| 366 | DTIL | Precision BioSciences, Inc. | 101.82M | -1.40% | 162,937 | 698.00K |
| 367 | ZNTL | Zentalis Pharmaceuticals, Inc. | 98.26M | -1.45% | 555,837 | 26.87M |
| 368 | ETHZ | ETHZilla Corporation | 98.09M | 0.97% | 736,084 | 4.11M |
| 369 | STRO | Sutro Biopharma, Inc. | 97.89M | 6.88% | 106,472 | 105.65M |
| 370 | CSBR | Champions Oncology, Inc. | 96.93M | -0.99% | 39,848 | 58.42M |
| 371 | EXOZ | eXoZymes, Inc. | 96.37M | -7.86% | 5,260 | -700.00 |
| 372 | ANVS | Annovis Bio, Inc. | 95.41M | -1.64% | 286,933 | - |
| 373 | IPSC | Century Therapeutics, Inc. | 94.73M | 4.33% | 1,435,138 | 113.34M |
| 374 | BMEA | Biomea Fusion, Inc. | 93.33M | 2.33% | 531,136 | - |
| 375 | VANI | Vivani Medical, Inc. | 92.65M | -4.51% | 304,600 | - |
| 376 | CBUS | Cibus, Inc. | 92.28M | -2.86% | 82,266 | 3.79M |
| 377 | SPRB | Spruce Biosciences, Inc. | 91.77M | 2.07% | 36,870 | 697.00K |
| 378 | EQ | Equillium, Inc. | 91.34M | -6.83% | 1,033,279 | 4.39M |
| 379 | THAR | Tharimmune, Inc. | 90.77M | 1.17% | 134,588 | - |
| 380 | CALC | CalciMedica, Inc. | 89.77M | 0.32% | 243,817 | - |
| 381 | ATOS | Atossa Therapeutics, Inc. | 85.11M | -3.99% | 977,522 | - |
| 382 | ACET | Adicet Bio, Inc. | 84.08M | 0.15% | 2,961,921 | - |
| 383 | ADAG | Adagene Inc. | 83.89M | -3.78% | 14,664 | 103.20K |
| 384 | VXRT | Vaxart, Inc. | 82.89M | -3.89% | 511,723 | 148.20M |
| 385 | TTRX | Turn Therapeutics Inc. | 80.68M | -7.74% | 50,347 | - |
| 386 | PSTV | Plus Therapeutics, Inc. | 79.70M | 1.40% | 1,945,620 | 5.26M |
| 387 | HYFT | MindWalk Holdings Corp. | 79.38M | -1.16% | 81,099 | 19.02M |
| 388 | PTHS | Pelthos Therapeutics Inc. | 79.36M | -2.98% | 2,161 | 7.41M |
| 389 | ENTX | Entera Bio Ltd. | 78.87M | -1.15% | 291,512 | 124.00K |
| 390 | COEP | Coeptis Therapeutics Holdings, Inc. | 78.23M | -3.36% | 57,065 | 501.00K |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 76.99M | 2.09% | 180,220 | - |
| 392 | TIL | Instil Bio, Inc. | 76.70M | -1.31% | 39,151 | - |
| 393 | KRRO | Korro Bio, Inc. | 76.47M | -3.45% | 99,854 | 7.37M |
| 394 | BYSI | BeyondSpring Inc. | 75.67M | -4.17% | 69,500 | 1.88M |
| 395 | TVGN | Tevogen Bio Holdings Inc. | 75.64M | -3.84% | 313,909 | - |
| 396 | XBIT | XBiotech Inc. | 75.30M | -0.40% | 13,604 | - |
| 397 | OKYO | OKYO Pharma Limited | 74.85M | -1.97% | 60,581 | - |
| 398 | CRVO | CervoMed Inc. | 74.76M | -4.72% | 22,760 | 6.16M |
| 399 | IFRX | InflaRx N.V. | 74.52M | -3.51% | 515,339 | 73.73K |
| 400 | PLRX | Pliant Therapeutics, Inc. | 74.35M | -1.63% | 510,947 | - |
| 401 | ATYR | aTyr Pharma, Inc. | 72.78M | 0.64% | 1,712,790 | 190.00K |
| 402 | ALXO | ALX Oncology Holdings Inc. | 72.11M | -2.21% | 74,640 | - |
| 403 | NRXP | NRx Pharmaceuticals, Inc. | 71.93M | 4.92% | 499,924 | 242.00K |
| 404 | PYXS | Pyxis Oncology, Inc. | 69.11M | - | 1,610,040 | 2.82M |
| 405 | PYPD | PolyPid Ltd. | 67.70M | 1.24% | 29,203 | - |
| 406 | IMUX | Immunic, Inc. | 67.52M | -3.94% | 1,826,086 | - |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 65.98M | 1.64% | 52,792 | - |
| 408 | RADX | Radiopharm Theranostics Limited | 64.21M | 0.18% | 99,852 | 8.20M |
| 409 | MGX | Metagenomi, Inc. | 63.83M | -2.30% | 273,946 | 30.91M |
| 410 | MNOV | MediciNova, Inc. | 62.42M | -0.78% | 181,880 | 257.92K |
| 411 | ALGS | Aligos Therapeutics, Inc. | 62.21M | -3.99% | 29,597 | 2.65M |
| 412 | ATHE | Alterity Therapeutics Limited | 62.02M | 2.42% | 14,131 | 3.57M |
| 413 | IMA | ImageneBio, Inc. | 61.78M | -0.85% | 30,105 | 800.00K |
| 414 | ANL | Adlai Nortye Ltd. | 60.52M | 7.19% | 70,929 | 1.94M |
| 415 | TCRX | TScan Therapeutics, Inc. | 60.15M | 1.92% | 626,701 | 8.42M |
| 416 | NTRB | Nutriband Inc. | 58.35M | 1.27% | 12,831 | 2.28M |
| 417 | ESLA | Estrella Immunopharma, Inc. | 58.16M | -3.14% | 15,846 | - |
| 418 | MAIA | MAIA Biotechnology, Inc. | 58.14M | 6.08% | 766,902 | - |
| 419 | ABVC | ABVC BioPharma, Inc. | 57.28M | 4.29% | 92,801 | 797.92K |
| 420 | INKT | MiNK Therapeutics, Inc. | 56.10M | 0.42% | 7,425 | - |
| 421 | ICCC | ImmuCell Corporation | 55.36M | 5.52% | 336,406 | 27.77M |
| 422 | GLTO | Galecto, Inc. | 54.46M | 15.77% | 231,811 | - |
| 423 | OSTX | OS Therapies Incorporated | 53.17M | -0.66% | 288,525 | - |
| 424 | IOBT | IO Biotech, Inc. | 53.17M | 0.07% | 347,366 | - |
| 425 | GRCE | Grace Therapeutics, Inc. | 52.61M | 0.89% | 22,428 | - |
| 426 | IBO | Impact BioMedical Inc. | 52.12M | -2.33% | 72,770 | 25.00K |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 50.20M | 2.82% | 187,073 | - |
| 428 | LITS | Lite Strategy, Inc. | 49.66M | -2.88% | 970,043 | - |
| 429 | PDSB | PDS Biotechnology Corporation | 49.48M | 1.22% | 667,903 | - |
| 430 | BCAB | BioAtla, Inc. | 49.28M | 15.30% | 1,034,436 | 11.00M |
| 431 | JSPR | Jasper Therapeutics, Inc. | 49.25M | -3.83% | 442,428 | - |
| 432 | HURA | TuHURA Biosciences, Inc. | 48.32M | -3.36% | 403,886 | - |
| 433 | ATNM | Actinium Pharmaceuticals, Inc. | 47.42M | -4.40% | 136,279 | 90.00K |
| 434 | PTN | Palatin Technologies, Inc. | 47.18M | -8.69% | 73,362 | 8.85M |
| 435 | KZR | Kezar Life Sciences, Inc. | 46.43M | - | 10,893 | - |
| 436 | ANEB | Anebulo Pharmaceuticals, Inc. | 46.01M | -6.67% | 132,431 | - |
| 437 | INMB | INmune Bio, Inc. | 45.99M | -2.26% | 345,117 | 50.00K |
| 438 | NXTC | NextCure, Inc. | 44.77M | -0.16% | 15,145 | - |
| 439 | APLM | Apollomics, Inc. | 42.92M | 11.17% | 29,784 | 6.93M |
| 440 | EVAX | Evaxion A/S | 42.79M | 4.27% | 78,472 | 7.65M |
| 441 | IBIO | iBio, Inc. | 42.50M | 1.07% | 889,691 | 500.00K |
| 442 | NRXS | NeurAxis, Inc. | 41.76M | 2.62% | 77,376 | 3.36M |
| 443 | QTTB | Q32 Bio Inc. | 39.37M | - | 145,994 | - |
| 444 | JUNS | Jupiter Neurosciences, Inc. | 39.25M | 3.64% | 72,506 | - |
| 445 | LTRN | Lantern Pharma Inc. | 38.92M | 4.19% | 49,717 | - |
| 446 | TVRD | Tvardi Therapeutics, Inc. | 38.84M | 2.99% | 415,493 | - |
| 447 | VERU | Veru Inc. | 38.52M | 2.56% | 178,929 | 16.89M |
| 448 | XCUR | Exicure, Inc. | 38.18M | -0.17% | 41,057 | 500.00K |
| 449 | CELU | Celularity Inc. | 37.96M | 1.52% | 61,028 | 40.58M |
| 450 | OKUR | OnKure Therapeutics, Inc. | 37.93M | -1.75% | 100,066 | - |
| 451 | CVM | CEL-SCI Corporation | 37.76M | 0.64% | 62,210 | - |
| 452 | GBIO | Generation Bio Co. | 37.73M | 0.72% | 77,137 | 15.27M |
| 453 | BTAI | BioXcel Therapeutics, Inc. | 36.30M | -2.92% | 336,219 | 752.00K |
| 454 | FGEN | FibroGen, Inc. | 36.00M | 3.61% | 28,658 | 8.30M |
| 455 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 35.31M | 10.40% | 7,882,998 | - |
| 456 | XLO | Xilio Therapeutics, Inc. | 34.75M | -0.51% | 218,470 | 31.80M |
| 457 | PASG | Passage Bio, Inc. | 34.52M | -0.28% | 21,462 | - |
| 458 | DYAI | Dyadic International, Inc. | 34.45M | -3.31% | 57,284 | 3.34M |
| 459 | GNTA | Genenta Science S.p.A. | 34.21M | - | 50,808 | - |
| 460 | QNTM | Quantum BioPharma Ltd. | 33.49M | -4.49% | 64,359 | - |
| 461 | RNTX | Rein Therapeutics Inc. | 32.60M | -6.06% | 407,756 | - |
| 462 | HOWL | Werewolf Therapeutics, Inc. | 31.76M | -0.92% | 670,046 | 1.14M |
| 463 | HYPD | Hyperion DeFi, Inc. | 31.38M | -4.48% | 138,263 | 345.32K |
| 464 | RNXT | RenovoRx, Inc. | 31.32M | -4.56% | 289,669 | 928.00K |
| 465 | ANTX | AN2 Therapeutics, Inc. | 31.24M | - | 35,613 | - |
| 466 | DARE | Daré Bioscience, Inc. | 30.72M | -0.92% | 90,663 | -57.13K |
| 467 | ATHA | Athira Pharma, Inc. | 29.50M | 3.74% | 139,520 | - |
| 468 | NERV | Minerva Neurosciences, Inc. | 29.30M | 5.54% | 54,065 | - |
| 469 | RLYB | Rallybio Corporation | 29.05M | -6.01% | 338,576 | 674.00K |
| 470 | LPCN | Lipocine Inc. | 29.04M | 12.47% | 139,527 | 4.32M |
| 471 | PLUR | Pluri Inc. | 28.78M | -3.12% | 31,649 | 1.33M |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 28.77M | 0.07% | 2,708,332 | 721.00K |
| 473 | BRNS | Barinthus Biotherapeutics plc | 28.75M | -1.50% | 159,885 | 14.97M |
| 474 | SER | Serina Therapeutics, Inc. | 28.37M | 9.02% | 17,633 | 116.00K |
| 475 | CING | Cingulate Inc. | 28.24M | 3.47% | 155,492 | - |
| 476 | SNTI | Senti Biosciences, Inc. | 27.87M | -7.83% | 621,371 | - |
| 477 | IGC | IGC Pharma, Inc. | 27.85M | -1.09% | 339,624 | 1.11M |
| 478 | BOLD | Boundless Bio, Inc. | 26.86M | -0.83% | 25,606 | - |
| 479 | SKYE | Skye Bioscience, Inc. | 25.65M | -4.12% | 551,925 | - |
| 480 | CUE | Cue Biopharma, Inc. | 25.57M | 34.77% | 7,193,622 | 7.10M |
| 481 | KLTO | Klotho Neurosciences, Inc. | 25.14M | -4.75% | 614,208 | - |
| 482 | KTTA | Pasithea Therapeutics Corp. | 25.09M | -4.27% | 147,483 | - |
| 483 | MRKR | Marker Therapeutics, Inc. | 23.93M | 3.24% | 140,412 | 4.69M |
| 484 | INTS | Intensity Therapeutics, Inc. | 23.59M | -3.42% | 742,415 | - |
| 485 | NNVC | NanoViricides, Inc. | 23.24M | - | 268,002 | - |
| 486 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.22M | 0.49% | 38,006 | - |
| 487 | LNAI | Lunai Bioworks Inc. | 22.75M | -1.53% | 144,847 | - |
| 488 | MTVA | MetaVia Inc. | 20.23M | -5.84% | 13,583 | - |
| 489 | NRSN | NeuroSense Therapeutics Ltd. | 20.03M | -2.14% | 255,547 | - |
| 490 | NEUP | Neuphoria Therapeutics Inc. | 20.00M | -1.06% | 24,285 | 15.65M |
| 491 | VYNE | VYNE Therapeutics Inc. | 19.57M | 0.94% | 1,532,568 | 524.00K |
| 492 | CLGN | CollPlant Biotechnologies Ltd. | 19.55M | 4.08% | 79,845 | 2.48M |
| 493 | ENLV | Enlivex Therapeutics Ltd. | 18.16M | -3.27% | 408,472 | - |
| 494 | GDTC | CytoMed Therapeutics Limited | 17.66M | -0.65% | 13,407 | 573.19K |
| 495 | LIMN | Liminatus Pharma, Inc. | 17.51M | -8.60% | 186,915 | - |
| 496 | CTXR | Citius Pharmaceuticals, Inc. | 17.46M | 5.02% | 1,325,065 | - |
| 497 | LSTA | Lisata Therapeutics, Inc. | 17.38M | -3.90% | 29,264 | 1.07M |
| 498 | CVKD | Cadrenal Therapeutics, Inc. | 17.33M | 0.54% | 31,086 | - |
| 499 | ALLR | Allarity Therapeutics, Inc. | 16.91M | 1.90% | 59,325 | - |
| 500 | PMN | ProMIS Neurosciences, Inc. | 16.49M | -7.38% | 24,102 | - |
| 501 | APLT | Applied Therapeutics, Inc. | 16.44M | -1.30% | 6,726,220 | 1.00M |
| 502 | OSRH | OSR Holdings, Inc. | 16.27M | 8.90% | 651,268 | -90.52K |
| 503 | CASI | CASI Pharmaceuticals, Inc. | 16.22M | 0.96% | 35,995 | 26.85M |
| 504 | PLRZ | Polyrizon Ltd. | 16.07M | 6.96% | 59,460 | - |
| 505 | CANF | Can-Fite BioPharma Ltd. | 16.03M | 18.64% | 176,288,719 | 560.00K |
| 506 | ITRM | Iterum Therapeutics plc | 15.93M | -3.95% | 667,807 | 390.00K |
| 507 | HOTH | Hoth Therapeutics, Inc. | 15.67M | -2.88% | 220,657 | - |
| 508 | BCTX | BriaCell Therapeutics Corp. | 15.48M | -4.33% | 38,524 | - |
| 509 | FBLG | FibroBiologics, Inc. | 15.26M | 5.55% | 1,449,748 | - |
| 510 | KAPA | Kairos Pharma, Ltd. | 14.74M | -4.61% | 390,655 | - |
| 511 | TPST | Tempest Therapeutics, Inc. | 14.73M | -2.92% | 71,010 | - |
| 512 | SYBX | Synlogic, Inc. | 14.27M | 4.27% | 29,823 | 8.00K |
| 513 | KZIA | Kazia Therapeutics Limited | 13.89M | -5.37% | 146,071 | 1.20M |
| 514 | SNGX | Soligenix, Inc. | 13.82M | -4.86% | 227,871 | 2.34K |
| 515 | NCNA | NuCana plc | 13.78M | -0.90% | 66,357 | - |
| 516 | CRIS | Curis, Inc. | 13.70M | 0.95% | 72,736 | 11.65M |
| 517 | BCDA | BioCardia, Inc. | 13.48M | - | 29,650 | 3.00K |
| 518 | COCP | Cocrystal Pharma, Inc. | 13.41M | -0.16% | 77,466 | - |
| 519 | LEXX | Lexaria Bioscience Corp. | 13.21M | -5.20% | 1,094,901 | 705.92K |
| 520 | BLRX | BioLineRx Ltd. | 13.07M | -1.02% | 18,251 | 12.74M |
| 521 | ABP | Abpro Holdings, Inc. | 12.49M | -2.75% | 6,963 | 183.00K |
| 522 | AEON | AEON Biopharma, Inc. | 12.08M | -2.86% | 140,787 | - |
| 523 | EDSA | Edesa Biotech, Inc. | 12.00M | 10.77% | 83,069 | - |
| 524 | MBRX | Moleculin Biotech, Inc. | 11.80M | -1.79% | 90,739 | - |
| 525 | QNRX | Quoin Pharmaceuticals, Ltd. | 11.74M | 0.65% | 11,343 | - |
| 526 | PHIO | Phio Pharmaceuticals Corp. | 11.63M | 2.86% | 207,315 | - |
| 527 | ASBP | Aspire Biopharma Holdings, Inc. | 11.61M | 11.34% | 19,546,815 | 1.94K |
| 528 | NCEL | NewcelX Ltd. | 11.40M | -4.94% | 11,815 | - |
| 529 | LGVN | Longeveron Inc. | 11.36M | 0.02% | 158,232 | 1.44M |
| 530 | SNSE | Sensei Biotherapeutics, Inc. | 11.35M | -2.81% | 21,035 | - |
| 531 | CMMB | Chemomab Therapeutics Ltd. | 11.08M | -4.26% | 146,390 | - |
| 532 | CLRB | Cellectar Biosciences, Inc. | 10.85M | -7.25% | 110,891 | - |
| 533 | INAB | IN8bio, Inc. | 10.33M | 11.50% | 291,261 | - |
| 534 | BOLT | Bolt Biotherapeutics, Inc. | 10.23M | 2.50% | 41,977 | 5.20M |
| 535 | APVO | Aptevo Therapeutics Inc. | 10.23M | -34.73% | 14,648,885 | - |
| 536 | GRDX | GridAI Technologies Corp. | 10.02M | 16.86% | 291,805 | - |
| 537 | BRTX | BioRestorative Therapies, Inc. | 9.94M | -5.88% | 39,001 | 383.40K |
| 538 | IMNN | Imunon, Inc. | 9.67M | -4.83% | 66,128 | - |
| 539 | ERNA | Ernexa Therapeutics Inc. | 9.50M | -4.72% | 13,815 | 1,000.00 |
| 540 | AKTX | Akari Therapeutics, Plc | 9.50M | -0.56% | 1,075,925 | - |
| 541 | TRAW | Traws Pharma, Inc. | 9.35M | -5.65% | 121,929 | 2.85M |
| 542 | APM | Aptorum Group Limited | 9.28M | -2.56% | 21,401 | - |
| 543 | ICU | SeaStar Medical Holding Corporation | 9.23M | 5.83% | 1,729,248 | 881.00K |
| 544 | BIVI | BioVie Inc. | 9.12M | -4.72% | 226,692 | - |
| 545 | CLDI | Calidi Biotherapeutics, Inc. | 9.07M | -3.88% | 46,059 | - |
| 546 | PCSA | Processa Pharmaceuticals, Inc. | 8.88M | 11.68% | 246,441 | - |
| 547 | GTBP | GT Biopharma, Inc. | 8.85M | -1.49% | 1,953,429 | - |
| 548 | EVGN | Evogene Ltd. | 8.78M | -1.43% | 53,975 | 8.02M |
| 549 | PULM | Pulmatrix, Inc. | 8.55M | 2.18% | 22,215 | 3.00K |
| 550 | IMRN | Immuron Limited | 8.28M | 0.47% | 43,494 | 4.78M |
| 551 | ADXN | Addex Therapeutics Ltd | 8.24M | -2.56% | 3,098 | 198.82K |
| 552 | PPCB | Propanc Biopharma, Inc. | 7.83M | -11.24% | 104,870 | - |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 7.76M | -5.41% | 55,406 | 6.00K |
| 554 | ALZN | Alzamend Neuro, Inc. | 7.68M | -1.46% | 88,040 | - |
| 555 | MBIO | Mustang Bio, Inc. | 7.44M | -2.86% | 140,805 | - |
| 556 | BGMS | Bio Green Med Solution, Inc. | 7.25M | 4.23% | 41,482 | 81.00K |
| 557 | KPRX | Kiora Pharmaceuticals, Inc. | 7.23M | -3.90% | 13,884 | 20.00K |
| 558 | TCRT | Alaunos Therapeutics, Inc. | 7.21M | -8.24% | 82,870 | 6.00K |
| 559 | PMCB | PharmaCyte Biotech, Inc. | 7.20M | -7.18% | 721,078 | - |
| 560 | SLXN | Silexion Therapeutics Corp | 7.16M | -2.97% | 36,168 | - |
| 561 | PPBT | Purple Biotech Ltd | 6.98M | - | 62,071 | - |
| 562 | KALA | KALA BIO, Inc. | 6.97M | 1.53% | 928,703 | - |
| 563 | XTLB | XTL Biopharmaceuticals Ltd. | 6.89M | -5.74% | 88,506 | 451.00K |
| 564 | ACXP | Acurx Pharmaceuticals, Inc. | 6.65M | -7.80% | 47,110 | - |
| 565 | TOVX | Theriva Biologics, Inc. | 6.45M | -1.70% | 1,100,725 | - |
| 566 | RNAZ | TransCode Therapeutics, Inc. | 6.38M | -6.33% | 15,437 | - |
| 567 | LYRA | Lyra Therapeutics, Inc. | 6.37M | 0.28% | 32,335 | 600.00K |
| 568 | ADIL | Adial Pharmaceuticals, Inc. | 6.20M | -2.88% | 284,293 | - |
| 569 | APRE | Aprea Therapeutics, Inc. | 6.19M | 3.05% | 22,781 | 488.24K |
| 570 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.08M | -2.63% | 8,097 | 15.78K |
| 571 | GOVX | GeoVax Labs, Inc. | 5.38M | -0.39% | 2,250,775 | 3.35M |
| 572 | VIVS | VivoSim Labs, Inc. | 5.24M | -3.37% | 36,282 | 140.00K |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 5.14M | -2.17% | 32,891 | 2.86M |
| 574 | REVB | Revelation Biosciences, Inc. | 5.09M | -1.14% | 54,011 | - |
| 575 | JAGX | Jaguar Health, Inc. | 4.95M | -3.54% | 126,216 | 11.79M |
| 576 | SILO | Silo Pharma, Inc. | 4.85M | -5.40% | 92,230 | 72.10K |
| 577 | SPRC | SciSparc Ltd. | 4.82M | 5.00% | 5,686,059 | 1.31M |
| 578 | XBIO | Xenetic Biosciences, Inc. | 4.77M | -5.45% | 54,817 | 2.86M |
| 579 | GLMD | Galmed Pharmaceuticals Ltd. | 4.74M | -1.73% | 35,123 | - |
| 580 | INDP | Indaptus Therapeutics, Inc. | 4.47M | -3.77% | 951,338 | - |
| 581 | ENVB | Enveric Biosciences, Inc. | 4.21M | -11.42% | 78,055 | - |
| 582 | GNPX | Genprex, Inc. | 4.15M | -3.76% | 119,981 | - |
| 583 | XRTX | XORTX Therapeutics Inc. | 4.11M | -0.96% | 57,447 | - |
| 584 | ENSC | Ensysce Biosciences, Inc. | 4.00M | -0.90% | 61,024 | 4.49M |
| 585 | MTNB | Matinas BioPharma Holdings, Inc. | 3.97M | -10.45% | 53,649 | - |
| 586 | SLRX | Salarius Pharmaceuticals, Inc. | 3.85M | 3.35% | 98,784 | - |
| 587 | HCWB | HCW Biologics Inc. | 3.84M | -4.38% | 37,813 | 422.03K |
| 588 | CNSP | CNS Pharmaceuticals, Inc. | 3.83M | -0.48% | 27,447 | - |
| 589 | OGEN | Oragenics, Inc. | 3.58M | 2.86% | 78,201 | - |
| 590 | CMND | Clearmind Medicine Inc. | 3.31M | -3.49% | 72,597 | - |
| 591 | AZTR | Azitra, Inc. | 3.23M | -4.02% | 255,950 | 7.50K |
| 592 | ARTL | Artelo Biosciences, Inc. | 3.01M | -5.70% | 49,379 | - |
| 593 | PHGE | BiomX Inc. | 2.95M | -3.50% | 46,470 | - |
| 594 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.94M | 1.00% | 195,867 | 1.36M |
| 595 | PTIX | Protagenic Therapeutics, Inc. | 2.56M | 15.22% | 67,968 | - |
| 596 | VRAX | Virax Biolabs Group Limited | 2.35M | -2.95% | 108,505 | 2.99K |
| 597 | CDT | CDT Equity Inc. | 2.33M | -10.06% | 82,875 | - |
| 598 | SCNI | Scinai Immunotherapeutics Ltd. | 2.24M | -6.20% | 57,599 | 1.15M |
| 599 | ONCO | Onconetix, Inc. | 2.22M | -5.92% | 28,906 | 1.22M |
| 600 | ADTX | Aditxt, Inc. | 1.99M | -1.75% | 324,122 | 5.95K |
| 601 | DRMA | Dermata Therapeutics, Inc. | 1.91M | -21.52% | 684,457 | - |
| 602 | PBM | Psyence Biomedical Ltd. | 1.74M | 4.49% | 426,071 | - |
| 603 | BDRX | Biodexa Pharmaceuticals Plc | 1.63M | -7.07% | 3,405,997 | 104.90K |
| 604 | ELAB | PMGC Holdings Inc. | 1.15M | -3.13% | 221,779 | 285.95K |
| 605 | MLEC | Moolec Science SA | 964.25K | 6.99% | 41,645 | 7.83M |
| 606 | GRI | GRI Bio, Inc. | 902.17K | -14.55% | 4,453,351 | - |